Premier Alternatives

Laminar Pharma

Palma de Mallorca, Spain · Founded 2006 · Privately Held (backing)

Operator of a biopharmaceutical company intended to focus on the discovery of membrane-lipid therapy-based drugs. Laminar Pharma is based in Palma de Mallorca, Spain and was founded in 2006. Its last known valuation is $168 million. It has raised $46 million.

Last price · $/share
—
Implied valuation
$168.0M
Total raised
$46.0M
Last round
—
What is Laminar Pharma worth?
$168.0Mlast known valuation
Free account
More of Laminar Pharma with a free account
  • ·Watch Laminar Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Laminar Pharma funding history

No rounds on record

No funding rounds for Laminar Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Laminar Pharma valuation

Laminar Pharma's last known valuation is $168 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Laminar Pharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Laminar Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Laminar Pharma

What is Laminar Pharma worth?
Laminar Pharma's last known valuation is $168.0M.
How much has Laminar Pharma raised?
Laminar Pharma has raised $46.0M in total funding across its recorded rounds.